focus -WSS

focus

author：knowledge 2025-09-06 05:26:40 - browse：71627

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Cancer researcher Catriona Jamieson is sending tumors into space

WSS

Cancer researcher Catriona Jamieson is sending tumors into space

Medical bills so high, Medicare adding extra digits to claim forms

H5N1 communication has been strictly for the birds

MassMutual is introducing free genetic testing for members

Study: People of West African ancestry at greater risk of cardiac amyloidosis

First recipient of genetically engineered pig kidney has died

entertainment

focus

explore

The cancer drug shortage isn’t new — and neither are the solutions

CDC wastewater surveillance dashboard to track bird flu hotspots

Duchenne breakthrough therapy leaves behind pioneering families

Q&A: Jennifer Adair on making gene therapy available globally

The high cost of giving birth even with insurance

Researchers on aging grapple with how to calculate biological age

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Cell therapy fails to slow type 1 diabetes, but safety is established

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Dogs on Prozac: What pet anti

focus

More tobacco lobbyists active in statehouses

Exact Sciences stock tumbles despite strong cancer detection sales

Melinda French Gates resigns from Gates Foundation

Diversity in clinical trials starts with building trust, experts say

More tobacco lobbyists active in statehouses

Orangutan used medicinal plant to treat wound, first time ever seen

focus

entertainment

leisure time

leisure time